nodes	percent_of_prediction	percent_of_DWPC	metapath
Bimatoprost—Corneal erosion—Dexamethasone—psoriatic arthritis	0.0253	0.0253	CcSEcCtD
Bimatoprost—Corneal erosion—Betamethasone—psoriatic arthritis	0.0253	0.0253	CcSEcCtD
Bimatoprost—Corneal oedema—Dexamethasone—psoriatic arthritis	0.0253	0.0253	CcSEcCtD
Bimatoprost—Corneal oedema—Betamethasone—psoriatic arthritis	0.0253	0.0253	CcSEcCtD
Bimatoprost—Vitreous floaters—Dexamethasone—psoriatic arthritis	0.0234	0.0234	CcSEcCtD
Bimatoprost—Vitreous floaters—Betamethasone—psoriatic arthritis	0.0234	0.0234	CcSEcCtD
Bimatoprost—Sensation of foreign body—Prednisolone—psoriatic arthritis	0.0195	0.0195	CcSEcCtD
Bimatoprost—Conjunctival oedema—Betamethasone—psoriatic arthritis	0.0191	0.0191	CcSEcCtD
Bimatoprost—Conjunctival oedema—Dexamethasone—psoriatic arthritis	0.0191	0.0191	CcSEcCtD
Bimatoprost—Sensation of foreign body—Betamethasone—psoriatic arthritis	0.0163	0.0163	CcSEcCtD
Bimatoprost—Conjunctival haemorrhage—Dexamethasone—psoriatic arthritis	0.0163	0.0163	CcSEcCtD
Bimatoprost—Conjunctival haemorrhage—Betamethasone—psoriatic arthritis	0.0163	0.0163	CcSEcCtD
Bimatoprost—Sensation of foreign body—Dexamethasone—psoriatic arthritis	0.0163	0.0163	CcSEcCtD
Bimatoprost—Hypertrichosis—Triamcinolone—psoriatic arthritis	0.0154	0.0154	CcSEcCtD
Bimatoprost—Hypertrichosis—Methylprednisolone—psoriatic arthritis	0.0154	0.0154	CcSEcCtD
Bimatoprost—Conjunctival hyperaemia—Prednisolone—psoriatic arthritis	0.0145	0.0145	CcSEcCtD
Bimatoprost—Hypertrichosis—Betamethasone—psoriatic arthritis	0.014	0.014	CcSEcCtD
Bimatoprost—Hypertrichosis—Dexamethasone—psoriatic arthritis	0.014	0.014	CcSEcCtD
Bimatoprost—Chronic obstructive pulmonary disease—Methotrexate—psoriatic arthritis	0.0135	0.0135	CcSEcCtD
Bimatoprost—Hypertrichosis—Prednisone—psoriatic arthritis	0.0122	0.0122	CcSEcCtD
Bimatoprost—Conjunctival hyperaemia—Betamethasone—psoriatic arthritis	0.0121	0.0121	CcSEcCtD
Bimatoprost—Conjunctival hyperaemia—Dexamethasone—psoriatic arthritis	0.0121	0.0121	CcSEcCtD
Bimatoprost—Hirsutism—Prednisolone—psoriatic arthritis	0.0109	0.0109	CcSEcCtD
Bimatoprost—Hirsutism—Triamcinolone—psoriatic arthritis	0.0101	0.0101	CcSEcCtD
Bimatoprost—Hirsutism—Methylprednisolone—psoriatic arthritis	0.01	0.01	CcSEcCtD
Bimatoprost—Skin hyperpigmentation—Triamcinolone—psoriatic arthritis	0.00984	0.00984	CcSEcCtD
Bimatoprost—Skin hyperpigmentation—Methylprednisolone—psoriatic arthritis	0.00982	0.00982	CcSEcCtD
Bimatoprost—Keratitis—Prednisolone—psoriatic arthritis	0.00981	0.00981	CcSEcCtD
Bimatoprost—Visual impairment—Auranofin—psoriatic arthritis	0.00966	0.00966	CcSEcCtD
Bimatoprost—Eye disorder—Auranofin—psoriatic arthritis	0.00936	0.00936	CcSEcCtD
Bimatoprost—Hirsutism—Dexamethasone—psoriatic arthritis	0.00914	0.00914	CcSEcCtD
Bimatoprost—Hirsutism—Betamethasone—psoriatic arthritis	0.00914	0.00914	CcSEcCtD
Bimatoprost—Skin hyperpigmentation—Betamethasone—psoriatic arthritis	0.00893	0.00893	CcSEcCtD
Bimatoprost—Skin hyperpigmentation—Dexamethasone—psoriatic arthritis	0.00893	0.00893	CcSEcCtD
Bimatoprost—Blepharitis—Betamethasone—psoriatic arthritis	0.00863	0.00863	CcSEcCtD
Bimatoprost—Blepharitis—Dexamethasone—psoriatic arthritis	0.00863	0.00863	CcSEcCtD
Bimatoprost—Keratitis—Dexamethasone—psoriatic arthritis	0.00819	0.00819	CcSEcCtD
Bimatoprost—Keratitis—Betamethasone—psoriatic arthritis	0.00819	0.00819	CcSEcCtD
Bimatoprost—Hirsutism—Prednisone—psoriatic arthritis	0.00796	0.00796	CcSEcCtD
Bimatoprost—Stinging—Prednisolone—psoriatic arthritis	0.00785	0.00785	CcSEcCtD
Bimatoprost—Eye irritation—Prednisolone—psoriatic arthritis	0.00745	0.00745	CcSEcCtD
Bimatoprost—Stinging—Triamcinolone—psoriatic arthritis	0.00722	0.00722	CcSEcCtD
Bimatoprost—Stinging—Betamethasone—psoriatic arthritis	0.00655	0.00655	CcSEcCtD
Bimatoprost—Stinging—Dexamethasone—psoriatic arthritis	0.00655	0.00655	CcSEcCtD
Bimatoprost—Skin hyperpigmentation—Methotrexate—psoriatic arthritis	0.0065	0.0065	CcSEcCtD
Bimatoprost—Cough increased—Triamcinolone—psoriatic arthritis	0.00639	0.00639	CcSEcCtD
Bimatoprost—Dyspepsia—Auranofin—psoriatic arthritis	0.00627	0.00627	CcSEcCtD
Bimatoprost—Cataract—Triamcinolone—psoriatic arthritis	0.00615	0.00615	CcSEcCtD
Bimatoprost—Inflammation—Methylprednisolone—psoriatic arthritis	0.00602	0.00602	CcSEcCtD
Bimatoprost—Cataract—Dexamethasone—psoriatic arthritis	0.00558	0.00558	CcSEcCtD
Bimatoprost—Cataract—Betamethasone—psoriatic arthritis	0.00558	0.00558	CcSEcCtD
Bimatoprost—Burning sensation—Methotrexate—psoriatic arthritis	0.00556	0.00556	CcSEcCtD
Bimatoprost—Pruritus—Auranofin—psoriatic arthritis	0.00504	0.00504	CcSEcCtD
Bimatoprost—Dry eye—Dexamethasone—psoriatic arthritis	0.0049	0.0049	CcSEcCtD
Bimatoprost—Dry eye—Betamethasone—psoriatic arthritis	0.0049	0.0049	CcSEcCtD
Bimatoprost—Hypercholesterolaemia—Prednisone—psoriatic arthritis	0.00489	0.00489	CcSEcCtD
Bimatoprost—Visual disturbance—Prednisolone—psoriatic arthritis	0.00487	0.00487	CcSEcCtD
Bimatoprost—Cataract—Prednisone—psoriatic arthritis	0.00486	0.00486	CcSEcCtD
Bimatoprost—Rash—Auranofin—psoriatic arthritis	0.00449	0.00449	CcSEcCtD
Bimatoprost—Dermatitis—Auranofin—psoriatic arthritis	0.00448	0.00448	CcSEcCtD
Bimatoprost—Skin discolouration—Methotrexate—psoriatic arthritis	0.00428	0.00428	CcSEcCtD
Bimatoprost—Eye pain—Dexamethasone—psoriatic arthritis	0.00427	0.00427	CcSEcCtD
Bimatoprost—Eye pain—Betamethasone—psoriatic arthritis	0.00427	0.00427	CcSEcCtD
Bimatoprost—Dry skin—Prednisolone—psoriatic arthritis	0.00423	0.00423	CcSEcCtD
Bimatoprost—Nausea—Auranofin—psoriatic arthritis	0.00423	0.00423	CcSEcCtD
Bimatoprost—Visual disturbance—Dexamethasone—psoriatic arthritis	0.00407	0.00407	CcSEcCtD
Bimatoprost—Visual disturbance—Betamethasone—psoriatic arthritis	0.00407	0.00407	CcSEcCtD
Bimatoprost—Inflammation—Methotrexate—psoriatic arthritis	0.00398	0.00398	CcSEcCtD
Bimatoprost—Cystitis noninfective—Methotrexate—psoriatic arthritis	0.00377	0.00377	CcSEcCtD
Bimatoprost—Cystitis—Methotrexate—psoriatic arthritis	0.00373	0.00373	CcSEcCtD
Bimatoprost—Asthma—Triamcinolone—psoriatic arthritis	0.00367	0.00367	CcSEcCtD
Bimatoprost—Dry skin—Betamethasone—psoriatic arthritis	0.00353	0.00353	CcSEcCtD
Bimatoprost—Dry skin—Dexamethasone—psoriatic arthritis	0.00353	0.00353	CcSEcCtD
Bimatoprost—Bronchitis—Triamcinolone—psoriatic arthritis	0.00353	0.00353	CcSEcCtD
Bimatoprost—Bladder pain—Methotrexate—psoriatic arthritis	0.00349	0.00349	CcSEcCtD
Bimatoprost—Upper respiratory tract infection—Triamcinolone—psoriatic arthritis	0.00341	0.00341	CcSEcCtD
Bimatoprost—Visual impairment—Prednisolone—psoriatic arthritis	0.00308	0.00308	CcSEcCtD
Bimatoprost—Dry skin—Prednisone—psoriatic arthritis	0.00308	0.00308	CcSEcCtD
Bimatoprost—Visual disturbance—Methotrexate—psoriatic arthritis	0.00296	0.00296	CcSEcCtD
Bimatoprost—Rhinitis—Triamcinolone—psoriatic arthritis	0.00295	0.00295	CcSEcCtD
Bimatoprost—Rhinitis—Methylprednisolone—psoriatic arthritis	0.00294	0.00294	CcSEcCtD
Bimatoprost—Pharyngitis—Triamcinolone—psoriatic arthritis	0.00292	0.00292	CcSEcCtD
Bimatoprost—Connective tissue disorder—Methylprednisolone—psoriatic arthritis	0.00288	0.00288	CcSEcCtD
Bimatoprost—Visual impairment—Methylprednisolone—psoriatic arthritis	0.00283	0.00283	CcSEcCtD
Bimatoprost—Erythema—Prednisolone—psoriatic arthritis	0.00278	0.00278	CcSEcCtD
Bimatoprost—Eye disorder—Methylprednisolone—psoriatic arthritis	0.00274	0.00274	CcSEcCtD
Bimatoprost—Angiopathy—Methylprednisolone—psoriatic arthritis	0.00266	0.00266	CcSEcCtD
Bimatoprost—Mediastinal disorder—Methylprednisolone—psoriatic arthritis	0.00264	0.00264	CcSEcCtD
Bimatoprost—Vision blurred—Prednisolone—psoriatic arthritis	0.00262	0.00262	CcSEcCtD
Bimatoprost—Liver function test abnormal—Methotrexate—psoriatic arthritis	0.00259	0.00259	CcSEcCtD
Bimatoprost—Depression—Prednisone—psoriatic arthritis	0.00258	0.00258	CcSEcCtD
Bimatoprost—Visual impairment—Betamethasone—psoriatic arthritis	0.00257	0.00257	CcSEcCtD
Bimatoprost—Visual impairment—Dexamethasone—psoriatic arthritis	0.00257	0.00257	CcSEcCtD
Bimatoprost—Erythema—Triamcinolone—psoriatic arthritis	0.00256	0.00256	CcSEcCtD
Bimatoprost—Erythema—Methylprednisolone—psoriatic arthritis	0.00255	0.00255	CcSEcCtD
Bimatoprost—Vertigo—Prednisolone—psoriatic arthritis	0.0025	0.0025	CcSEcCtD
Bimatoprost—Eye disorder—Dexamethasone—psoriatic arthritis	0.00249	0.00249	CcSEcCtD
Bimatoprost—Eye disorder—Betamethasone—psoriatic arthritis	0.00249	0.00249	CcSEcCtD
Bimatoprost—Asthma—Methotrexate—psoriatic arthritis	0.00242	0.00242	CcSEcCtD
Bimatoprost—Angiopathy—Dexamethasone—psoriatic arthritis	0.00242	0.00242	CcSEcCtD
Bimatoprost—Angiopathy—Betamethasone—psoriatic arthritis	0.00242	0.00242	CcSEcCtD
Bimatoprost—Hypertension—Prednisolone—psoriatic arthritis	0.0024	0.0024	CcSEcCtD
Bimatoprost—Erythema—Dexamethasone—psoriatic arthritis	0.00232	0.00232	CcSEcCtD
Bimatoprost—Erythema—Betamethasone—psoriatic arthritis	0.00232	0.00232	CcSEcCtD
Bimatoprost—Vertigo—Triamcinolone—psoriatic arthritis	0.0023	0.0023	CcSEcCtD
Bimatoprost—Vertigo—Methylprednisolone—psoriatic arthritis	0.00229	0.00229	CcSEcCtD
Bimatoprost—Connective tissue disorder—Prednisone—psoriatic arthritis	0.00228	0.00228	CcSEcCtD
Bimatoprost—Upper respiratory tract infection—Methotrexate—psoriatic arthritis	0.00225	0.00225	CcSEcCtD
Bimatoprost—Cough—Triamcinolone—psoriatic arthritis	0.00223	0.00223	CcSEcCtD
Bimatoprost—Hypertension—Triamcinolone—psoriatic arthritis	0.00221	0.00221	CcSEcCtD
Bimatoprost—Hypertension—Methylprednisolone—psoriatic arthritis	0.0022	0.0022	CcSEcCtD
Bimatoprost—Eye disorder—Prednisone—psoriatic arthritis	0.00217	0.00217	CcSEcCtD
Bimatoprost—Anxiety—Methylprednisolone—psoriatic arthritis	0.00217	0.00217	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.00216	0.00216	CcSEcCtD
Bimatoprost—Depression—Methotrexate—psoriatic arthritis	0.00216	0.00216	CcSEcCtD
Bimatoprost—Dry mouth—Triamcinolone—psoriatic arthritis	0.00213	0.00213	CcSEcCtD
Bimatoprost—Angiopathy—Prednisone—psoriatic arthritis	0.00211	0.00211	CcSEcCtD
Bimatoprost—Vertigo—Dexamethasone—psoriatic arthritis	0.00209	0.00209	CcSEcCtD
Bimatoprost—Vertigo—Betamethasone—psoriatic arthritis	0.00209	0.00209	CcSEcCtD
Bimatoprost—Infection—Triamcinolone—psoriatic arthritis	0.00207	0.00207	CcSEcCtD
Bimatoprost—Infection—Methylprednisolone—psoriatic arthritis	0.00207	0.00207	CcSEcCtD
Bimatoprost—Insomnia—Prednisolone—psoriatic arthritis	0.00205	0.00205	CcSEcCtD
Bimatoprost—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.00204	0.00204	CcSEcCtD
Bimatoprost—Skin disorder—Methylprednisolone—psoriatic arthritis	0.00202	0.00202	CcSEcCtD
Bimatoprost—Erythema—Prednisone—psoriatic arthritis	0.00202	0.00202	CcSEcCtD
Bimatoprost—Hypertension—Betamethasone—psoriatic arthritis	0.002	0.002	CcSEcCtD
Bimatoprost—Hypertension—Dexamethasone—psoriatic arthritis	0.002	0.002	CcSEcCtD
Bimatoprost—Anxiety—Dexamethasone—psoriatic arthritis	0.00197	0.00197	CcSEcCtD
Bimatoprost—Anxiety—Betamethasone—psoriatic arthritis	0.00197	0.00197	CcSEcCtD
Bimatoprost—Pain—Prednisolone—psoriatic arthritis	0.00194	0.00194	CcSEcCtD
Bimatoprost—Pharyngitis—Methotrexate—psoriatic arthritis	0.00193	0.00193	CcSEcCtD
Bimatoprost—Vision blurred—Prednisone—psoriatic arthritis	0.0019	0.0019	CcSEcCtD
Bimatoprost—Insomnia—Triamcinolone—psoriatic arthritis	0.00189	0.00189	CcSEcCtD
Bimatoprost—Insomnia—Methylprednisolone—psoriatic arthritis	0.00188	0.00188	CcSEcCtD
Bimatoprost—Infection—Dexamethasone—psoriatic arthritis	0.00188	0.00188	CcSEcCtD
Bimatoprost—Infection—Betamethasone—psoriatic arthritis	0.00188	0.00188	CcSEcCtD
Bimatoprost—Visual impairment—Methotrexate—psoriatic arthritis	0.00187	0.00187	CcSEcCtD
Bimatoprost—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00186	0.00186	CcSEcCtD
Bimatoprost—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.00186	0.00186	CcSEcCtD
Bimatoprost—Nervous system disorder—Betamethasone—psoriatic arthritis	0.00186	0.00186	CcSEcCtD
Bimatoprost—Dyspepsia—Triamcinolone—psoriatic arthritis	0.00184	0.00184	CcSEcCtD
Bimatoprost—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.00183	0.00183	CcSEcCtD
Bimatoprost—Vertigo—Prednisone—psoriatic arthritis	0.00182	0.00182	CcSEcCtD
Bimatoprost—Eye disorder—Methotrexate—psoriatic arthritis	0.00181	0.00181	CcSEcCtD
Bimatoprost—Pain—Triamcinolone—psoriatic arthritis	0.00179	0.00179	CcSEcCtD
Bimatoprost—Angiopathy—Methotrexate—psoriatic arthritis	0.00176	0.00176	CcSEcCtD
Bimatoprost—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.00175	0.00175	CcSEcCtD
Bimatoprost—Hypertension—Prednisone—psoriatic arthritis	0.00175	0.00175	CcSEcCtD
Bimatoprost—Anxiety—Prednisone—psoriatic arthritis	0.00171	0.00171	CcSEcCtD
Bimatoprost—Insomnia—Dexamethasone—psoriatic arthritis	0.00171	0.00171	CcSEcCtD
Bimatoprost—Insomnia—Betamethasone—psoriatic arthritis	0.00171	0.00171	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.00171	0.00171	CcSEcCtD
Bimatoprost—Erythema—Methotrexate—psoriatic arthritis	0.00169	0.00169	CcSEcCtD
Bimatoprost—Dyspepsia—Dexamethasone—psoriatic arthritis	0.00167	0.00167	CcSEcCtD
Bimatoprost—Dyspepsia—Betamethasone—psoriatic arthritis	0.00167	0.00167	CcSEcCtD
Bimatoprost—Infection—Prednisone—psoriatic arthritis	0.00164	0.00164	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.00164	0.00164	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.00164	0.00164	CcSEcCtD
Bimatoprost—Pain—Betamethasone—psoriatic arthritis	0.00162	0.00162	CcSEcCtD
Bimatoprost—Pain—Dexamethasone—psoriatic arthritis	0.00162	0.00162	CcSEcCtD
Bimatoprost—Nervous system disorder—Prednisone—psoriatic arthritis	0.00162	0.00162	CcSEcCtD
Bimatoprost—Skin disorder—Prednisone—psoriatic arthritis	0.0016	0.0016	CcSEcCtD
Bimatoprost—Vision blurred—Methotrexate—psoriatic arthritis	0.00159	0.00159	CcSEcCtD
Bimatoprost—Vertigo—Methotrexate—psoriatic arthritis	0.00152	0.00152	CcSEcCtD
Bimatoprost—Dizziness—Prednisolone—psoriatic arthritis	0.0015	0.0015	CcSEcCtD
Bimatoprost—Asthenia—Triamcinolone—psoriatic arthritis	0.0015	0.0015	CcSEcCtD
Bimatoprost—Asthenia—Methylprednisolone—psoriatic arthritis	0.00149	0.00149	CcSEcCtD
Bimatoprost—Insomnia—Prednisone—psoriatic arthritis	0.00149	0.00149	CcSEcCtD
Bimatoprost—Pruritus—Triamcinolone—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Bimatoprost—Cough—Methotrexate—psoriatic arthritis	0.00147	0.00147	CcSEcCtD
Bimatoprost—Pruritus—Methylprednisolone—psoriatic arthritis	0.00147	0.00147	CcSEcCtD
Bimatoprost—Dyspepsia—Prednisone—psoriatic arthritis	0.00145	0.00145	CcSEcCtD
Bimatoprost—Chest pain—Methotrexate—psoriatic arthritis	0.00144	0.00144	CcSEcCtD
Bimatoprost—Rash—Prednisolone—psoriatic arthritis	0.00143	0.00143	CcSEcCtD
Bimatoprost—Dermatitis—Prednisolone—psoriatic arthritis	0.00143	0.00143	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.00143	0.00143	CcSEcCtD
Bimatoprost—Headache—Prednisolone—psoriatic arthritis	0.00142	0.00142	CcSEcCtD
Bimatoprost—Dizziness—Triamcinolone—psoriatic arthritis	0.00138	0.00138	CcSEcCtD
Bimatoprost—Dizziness—Methylprednisolone—psoriatic arthritis	0.00138	0.00138	CcSEcCtD
Bimatoprost—Infection—Methotrexate—psoriatic arthritis	0.00137	0.00137	CcSEcCtD
Bimatoprost—Asthenia—Betamethasone—psoriatic arthritis	0.00136	0.00136	CcSEcCtD
Bimatoprost—Asthenia—Dexamethasone—psoriatic arthritis	0.00136	0.00136	CcSEcCtD
Bimatoprost—Nervous system disorder—Methotrexate—psoriatic arthritis	0.00135	0.00135	CcSEcCtD
Bimatoprost—Nausea—Prednisolone—psoriatic arthritis	0.00135	0.00135	CcSEcCtD
Bimatoprost—Pruritus—Betamethasone—psoriatic arthritis	0.00134	0.00134	CcSEcCtD
Bimatoprost—Pruritus—Dexamethasone—psoriatic arthritis	0.00134	0.00134	CcSEcCtD
Bimatoprost—Skin disorder—Methotrexate—psoriatic arthritis	0.00134	0.00134	CcSEcCtD
Bimatoprost—Rash—Triamcinolone—psoriatic arthritis	0.00132	0.00132	CcSEcCtD
Bimatoprost—Dermatitis—Triamcinolone—psoriatic arthritis	0.00132	0.00132	CcSEcCtD
Bimatoprost—Rash—Methylprednisolone—psoriatic arthritis	0.00131	0.00131	CcSEcCtD
Bimatoprost—Dermatitis—Methylprednisolone—psoriatic arthritis	0.00131	0.00131	CcSEcCtD
Bimatoprost—Headache—Triamcinolone—psoriatic arthritis	0.00131	0.00131	CcSEcCtD
Bimatoprost—Headache—Methylprednisolone—psoriatic arthritis	0.0013	0.0013	CcSEcCtD
Bimatoprost—Dizziness—Betamethasone—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Bimatoprost—Dizziness—Dexamethasone—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Bimatoprost—Insomnia—Methotrexate—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Bimatoprost—Nausea—Triamcinolone—psoriatic arthritis	0.00124	0.00124	CcSEcCtD
Bimatoprost—Nausea—Methylprednisolone—psoriatic arthritis	0.00124	0.00124	CcSEcCtD
Bimatoprost—Dyspnoea—Methotrexate—psoriatic arthritis	0.00123	0.00123	CcSEcCtD
Bimatoprost—Somnolence—Methotrexate—psoriatic arthritis	0.00123	0.00123	CcSEcCtD
Bimatoprost—Dyspepsia—Methotrexate—psoriatic arthritis	0.00121	0.00121	CcSEcCtD
Bimatoprost—Rash—Dexamethasone—psoriatic arthritis	0.00119	0.00119	CcSEcCtD
Bimatoprost—Rash—Betamethasone—psoriatic arthritis	0.00119	0.00119	CcSEcCtD
Bimatoprost—Dermatitis—Betamethasone—psoriatic arthritis	0.00119	0.00119	CcSEcCtD
Bimatoprost—Dermatitis—Dexamethasone—psoriatic arthritis	0.00119	0.00119	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.00119	0.00119	CcSEcCtD
Bimatoprost—Headache—Betamethasone—psoriatic arthritis	0.00119	0.00119	CcSEcCtD
Bimatoprost—Headache—Dexamethasone—psoriatic arthritis	0.00119	0.00119	CcSEcCtD
Bimatoprost—Asthenia—Prednisone—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Bimatoprost—Pain—Methotrexate—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Bimatoprost—Pruritus—Prednisone—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Bimatoprost—Nausea—Betamethasone—psoriatic arthritis	0.00113	0.00113	CcSEcCtD
Bimatoprost—Nausea—Dexamethasone—psoriatic arthritis	0.00113	0.00113	CcSEcCtD
Bimatoprost—Dizziness—Prednisone—psoriatic arthritis	0.00109	0.00109	CcSEcCtD
Bimatoprost—Rash—Prednisone—psoriatic arthritis	0.00104	0.00104	CcSEcCtD
Bimatoprost—Dermatitis—Prednisone—psoriatic arthritis	0.00104	0.00104	CcSEcCtD
Bimatoprost—Headache—Prednisone—psoriatic arthritis	0.00103	0.00103	CcSEcCtD
Bimatoprost—Asthenia—Methotrexate—psoriatic arthritis	0.000989	0.000989	CcSEcCtD
Bimatoprost—Nausea—Prednisone—psoriatic arthritis	0.00098	0.00098	CcSEcCtD
Bimatoprost—Pruritus—Methotrexate—psoriatic arthritis	0.000975	0.000975	CcSEcCtD
Bimatoprost—Dizziness—Methotrexate—psoriatic arthritis	0.000912	0.000912	CcSEcCtD
Bimatoprost—Rash—Methotrexate—psoriatic arthritis	0.000869	0.000869	CcSEcCtD
Bimatoprost—Dermatitis—Methotrexate—psoriatic arthritis	0.000868	0.000868	CcSEcCtD
Bimatoprost—Headache—Methotrexate—psoriatic arthritis	0.000864	0.000864	CcSEcCtD
Bimatoprost—Nausea—Methotrexate—psoriatic arthritis	0.000819	0.000819	CcSEcCtD
